Loring Wolcott & Coolidge Fiduciary Advisors LLP Bio Rad Laboratories, Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

  • $11.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$657.71 - $825.77 $1,973 - $2,477
-3 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$576.64 - $649.04 $1,729 - $1,947
3 New
3 $2,000
Q1 2021

Apr 14, 2021
SELL
$547.01 - $662.35 $2,735 - $3,311
-5 Closed
0 $0
Q4 2020

Jan 14, 2021
BUY
$510.68 - $643.45 $2,553 - $3,217
5 New
5 $3,000
Q4 2017

Feb 08, 2018
SELL
$216.94 - $271.3 $1,301 - $1,627
-6 Closed
0 $0
Q3 2017

Oct 27, 2017
BUY
$212.27 - $242.28 $1,273 - $1,453
6
6 $1,000

Others Institutions Holding BIO

# of Institutions
456
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email